Author

Kaia Heimstreet

University of Wisconsin–Madison

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 2 Research Focus:cell type annotation· 1 Approach:deep learning· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Organism:mouse· 1

Frequent Co-Authors

Amy K. ErbeiD· 2 shared Alexander L. RakhmilevichiD· 1 shared Alina A. HamptoniD· 1 shared Anqi GaoiD· 1 shared Arika S. FeilsiD· 1 shared Belinda B. WenkeiD· 1 shared Bonnie Hammer· 1 shared Bryan T. Glaser· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Amy K. ErbeORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Bispecific GD2xB7-H3 Antibody Improves Tumor Targeting and Reduces Toxicity while Maintaining Efficacy for Neuroblastoma

Amy K. Erbe, Arika S. Feils, Sabrina Reinthaler, Alina A. Hampton, Zachary T. Rosenkrans, Yadira Medina-Guevara, Mildred A. R. Felder, Jessica M. Wiwczar, Daniel Gerhardt, Mark R. Bercher, Belinda B. Wenke, Callie Haertle, Mackenzie Heck, Kaia Heimstreet, Elizabeth Frankel, , PaulM. Sondel

This paper describes a bispecific antibody that targets GD2 and B7-H3 to improve tumor targeting and reduce toxicity in neuroblastoma treatment.

bioRxiv · Sep 22, 2026 · PreprintCancer Biology

Single-cell multi-omics analysis reveals heterogeneity and plasticity of neutrophil states in response to immunotherapies

Anqi Gao, Sananda Shyamkumar, Natalie B. Winn, Amy K. Erbe, Shelly M. Davis, Jennifer Zaborek, Kaia Heimstreet, Simon Boyenga, Joel A Matthews, Stella Tzu-Ming Tzu-Ming Tsao, Paul M. Sondel, Huy Q. Dinh

This study identifies treatment-induced neutrophil states in tumors using single-cell multi-omics, showing ICAM1 as a marker of anti-tumor activity and potential biomarker for immunotherapy response.

bioRxiv · Jul 3, 2026 · PreprintCancer Biology